Skip to content
Agree.net – Lifestyle
Author:
Scribe Therapeutics Inc.
Scribe Therapeutics Announces Closing of Initial Public Offering, Full Exercise of Underwriters’ Option to Purchase Additional Shares, and Closing of the Concurrent Private Placement
July 27, 2026
Scribe Therapeutics Announces Pricing of Upsized Initial Public Offering
July 23, 2026